PHARMATECH ONCOLOGY ANNOUNCES BEING ON-TARGET FOR SETTING A RECORD GROWTH YEAR FOR 2012
11/5/2012
PHARMATECH ONCOLOGY ANNOUNCES PROGRESSION TOWARDS COMMERCIALIZING ITS DOCUMENT MANAGEMENT SYSTEM
10/22/2012
PHARMATECH ONCOLOGY ANNOUNCES WENDY GARZA AS NEW CONTROLLER
8/25/2012
8/13/2012
Pharmatech Oncology Announces Collaboration with PCM Trials for In-Home Study Visits
5/3/2012
Increasing Focus On A Single Targeted Therapy
Our expertise covers Phase I, Phase II, Phase III and Phase IV trials in oncology. We have the largest network of oncologists in the United States and have developed a proprietary enrollment methodology called Just-In-Time which increases enrollment efficiency in trials while mitigating risk for sponsors. Whether you’re a global pharmaceutical company or a small biotech, Pharmatech will develop and execute on an enrollment strategy that integrates with your timelines and your budget.
- Phase I through Phase IV Studies - Learn More
- Investigator Sponsored Trials - Learn More
- Just-in-Time Logistics - Learn More
- Largest US-based Oncology Network - Learn More
- Access to more then 1 million cancer patients annually
- Top-Rated Rescue CRO/SMO - Learn More
- Flexible Service Model - Learn More






